Search

Your search keyword '"Schymanski, Emma L"' showing total 477 results

Search Constraints

Start Over You searched for: Author "Schymanski, Emma L" Remove constraint Author: "Schymanski, Emma L"
477 results on '"Schymanski, Emma L"'

Search Results

1. Beyond target chemicals: updating the NORMAN prioritisation scheme to support the EU chemicals strategy with semi-quantitative suspect/non-target screening data

5. Open access repository-scale propagated nearest neighbor suspect spectral library for untargeted metabolomics

6. NORMAN guidance on suspect and non-target screening in environmental monitoring

9. Harmonized quality assurance/quality control provisions to assess completeness and robustness of MS1 data preprocessing for LC-HRMS-based suspect screening and non-targeted analysis

14. Expanding the Use of Spectral Libraries in Proteomics

15. The NORMAN Suspect List Exchange (NORMAN-SLE): facilitating European and worldwide collaboration on suspect screening in high resolution mass spectrometry

19. Critical Assessment of Small Molecule Identification 2016: automated methods

20. Should Transformation Products Change the Way We Manage Chemicals?

22. Beyond Target Chemicals: Updating the NORMAN Prioritisation Scheme to Support the EU Chemical Strategy with Semi-quantitative Suspect/Non-target Screening Data

23. Quantification Approaches in Non-Target LC/ESI/HRMS Analysis: An Interlaboratory Comparison

24. Adopting Mechanistic Molecular Biology Approaches in Exposome Research for Causal Understanding

25. Adopting Mechanistic Molecular Biology Approaches in Exposome Research for Causal Understanding

26. Adopting Mechanistic Molecular Biology Approaches in Exposome Research for Causal Understanding

27. CLN3 deficiency leads to neurological and metabolic perturbations during early development

28. Dopamine-iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease

34. Retention projection enables accurate calculation of liquid chromatographic retention times across labs and methods

36. Contributors

39. ELIXIR and Toxicology: a community in development

41. Historical Exposomics: A Manifesto

42. Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients?

43. The NORMAN Association and the European Partnership for Chemicals Risk Assessment (PARC): let’s cooperate!

45. The 'cleanventory': Identifying the Chemical Structures of Persistent and Mobile Substances on Global Trade Markets

47. Non-target LC-HRMS to Study the Exposome of Mild Cognitive Impairment and Alzheimer's Disease on Cerebrospinal Fluid

Catalog

Books, media, physical & digital resources